Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Beijing Senmei Xikma Biotechnology Co., Ltd., established on 2009-10-22, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Import and export,Technology Import and Export,Agent import and export;Equipment Leasing(Items without administrative license);sell chemical products(Does not contain a class of precursors and dangerous chemicals),laboratory equipment(Except for projects subject to special approval),Class II Medical Devices,cosmetic;Medical Research and Experimental Development;Sales of Class III medical devices;Production No.IIclass of medical devices:2002Catalog:Class II:II-6840In vitro diagnostic reagents,II-6840-1blood analysis system2017Catalog:Class II:II-22-01blood analysis equipment(The medical device production license is valid until2023year12moon26day);Dedicated transport of goods(Refrigerated)(The road transport business license is valid until2024year07moon08day).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Dedicated transport of goods(Refrigerated),Production No.IIclass of medical devices:2002Catalog:IIkind:II-6840In vitro diagnostic reagents,II-6840-1blood analysis system2017Catalog:Class II:II-22-01blood analysis equipment,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Suzhou Huizhong Biotechnology Co., Ltd., established on 2020-07-21, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based materials technology;Biochemical product technology research and development;Fermentation process optimization technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Bonnierforetagen AB is a company headquartered in Sweden. The firm publishes books and magazines and provides printing services.

Xiamen Bosheng Biotechnology Co., Ltd., established on 2001-03-30, Business scope includes medical,Manufacturing of surgical and veterinary instruments;second,Wholesale of Class III Medical Devices;second,Retailing of Class III Medical Devices;Acquisition of agricultural and sideline products(Does not contain grains and seeds);Manage the export business of the company's self-produced products and the machinery and equipment needed by the company,spare parts,Import business of raw and auxiliary materials(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Engineering and Technology Research and Experimental Development;Manufacturing of chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals).

Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. Its products include cardiac, tumor, diabetes, hormone, infection, and rheumatoid arthritics tests. The company was founded on November 13, 1998 and is headquartered in Chuncheon-si, South Korea.

Shandong Labo Biotechnology Co., Ltd., established on 2005-05-13, The scope of business includes the production of medical devices,Sales;Disinfectant production(Free of Hazardous Chemicals);Disinfectant sales(Free of Hazardous Chemicals);glassware,Office Supplies,Sales of Electronics;Import and export(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Medical Device Repair,Leasing and technical consulting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Jifu Biotechnology Co., Ltd., established on 2013-06-27, Business scope includes biomedical technology development,consult,Serve,transfer.(If the above business scope involves industry licensing, the license certificate,Operate within the validity period,If the country has special franchise regulations, it shall be handled in accordance with the regulations.)

Jiangxi Danke Medical Technology Co., Ltd., established on 2020-01-21, Business scope includes licensed projects:Class III medical device business,food sales(Items subject to approval by law,Business activities can only be carried out within the validity period of the license after being approved by the relevant department,The specific business items and license period are subject to the approval documents or licenses of relevant departments) General project:Medical Research and Experimental Development,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Health Consulting Services(Does not include medical services),software development,Domestic trade agent,Business Management Consulting,Sales of Class I Medical Devices,Sales of Class II Medical Devices,Machinery and Equipment Leasing,Technology Import and Export,Import and export,Chemical product sales(No licensed chemical products),Conference and Exhibition Services,food sales(Only sell prepackaged food)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuhu Interfill Biological Products Industry Research Institute Co., Ltd., established on 2015-12-24, Business scope includes general items:Research and development of bio-based materials technology;Sales of bio-based materials;Bio-feed R&D;Manufacturing of bio-based materials;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Feed Additive Sales;Agricultural Science Research and Experimental Development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Retail;Cosmetics Wholesale;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Healthy food(prepackaged)Sales;Experimental analysis instrument sales(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)licensed items:Feed additive production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Disinfection equipment sales;Production of sterile equipment;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd. is a Chinese private company located in Chengdu. The firm manufactures pharmaceuticals.

Beijing Bell Medical Equipment Co., Ltd., established on 2013-06-17, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Machinery sales;Instrument sales;Class I Medical Device Leasing;Class II Medical Device Leasing;Import and export;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Chengdu Haimo Yunyin Medical Laboratory Co., Ltd., established on 2019-08-05, The scope of business includes medical laboratory;Medical technology development and technical services;Medical Research and Experimental Development;Biotechnology Extension Services;Genetic Testing Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.